A novel membrane glycoprotein capable of inhibiting membrane attack by homologous complement.

Abstract

Neuraminidase-treated human erythrocytes become sensitive to haemolysis by heterologous serum via activation of the alternative complement pathway (ACP), while remaining insensitive to homologous serum because of the presence of inhibitors on the cell membrane. We obtained a monoclonal antibody which renders the neuraminidase-treated erythrocytes sensitive… (More)

Topics

  • Presentations referencing similar topics